GBT
BMY icon

Grove Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Grove Bank & Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
22,434
+3,532
+19% +$203K 0.13% 99
2026
Q1 		$1.15M Buy
18,902
+314
+2% +$18.3K 0.13% 101
2025
Q4 		$1M Buy
18,588
+510
+3% +$24.5K 0.11% 116
2025
Q3 		$815K Sell
18,078
-1,451
-7% -$67.8K 0.1% 126
2025
Q2 		$904K Buy
19,529
+619
+3% +$30.4K 0.11% 118
2025
Q1 		$1.15M Buy
18,910
+360
+2% +$21K 0.15% 98
2024
Q4 		$1.05M Buy
18,550
+2,407
+15% +$134K 0.15% 98
2024
Q3 		$835K Buy
16,143
+1,240
+8% +$58.2K 0.12% 108
2024
Q2 		$619K Buy
14,903
+1,870
+14% +$83.7K 0.1% 128
2024
Q1 		$707K Buy
13,033
+8,218
+171% +$419K 0.12% 113
2023
Q4 		$247K Sell
4,815
-549
-10% -$28.8K 0.05% 195
2023
Q3 		$311K Sell
5,364
-891
-14% -$54.6K 0.06% 171
2023
Q2 		$400K Buy
6,255
+98
+2% +$6.57K 0.08% 155
2023
Q1 		$427K Buy
6,157
+527
+9% +$37.2K 0.09% 153
2022
Q4 		$405K Sell
5,630
-6,785
-55% -$512K 0.09% 164
2022
Q3 		$882K Buy
12,415
+844
+7% +$61.2K 0.22% 94
2022
Q2 		$891K Sell
11,571
-869
-7% -$66.2K 0.21% 97
2022
Q1 		$908K Buy
12,440
+4,174
+50% +$280K 0.18% 107
2021
Q4 		$516K Buy
8,266
+545
+7% +$32K 0.1% 148
2021
Q3 		$457K Sell
7,721
-1
-0% -$66 0.1% 149
2021
Q2 		$516K Sell
7,722
-42
-0.5% -$2.74K 0.11% 142
2021
Q1 		$490K Sell
7,764
-2,098
-21% -$131K 0.12% 139
2020
Q4 		$612K Buy
9,862
+1,052
+12% +$64.7K 0.16% 116
2020
Q3 		$532K Buy
8,810
+1,474
+20% +$88.7K 0.16% 116
2020
Q2 		$432K Buy
7,336
+1,616
+28% +$96.7K 0.14% 129
2020
Q1 		$318K Sell
5,720
-957
-14% -$58.5K 0.13% 135
2019
Q4 		$428K Buy
6,677
+321
+5% +$18.4K 0.13% 133
2019
Q3 		$322K Buy
6,356
+320
+5% +$15K 0.1% 146
2019
Q2 		$274K Sell
6,036
-868
-13% -$40.4K 0.1% 146
2019
Q1 		$329K Buy
6,904
+10
+0.1% +$498 0.13% 136
2018
Q4 		$358K Buy
6,894
+1,150
+20% +$61.8K 0.17% 120
2018
Q3 		$356K Sell
5,744
-535
-9% -$31.7K 0.15% 127
2018
Q2 		$348K Sell
6,279
-2,880
-31% -$156K 0.15% 130
2018
Q1 		$580K Hold
9,159
– – 0.26% 99
2017
Q4 		$561K Sell
9,159
-226
-2% -$14.1K 0.24% 95
2017
Q3 		$598K Buy
9,385
+35
+0.4% +$2.04K 0.29% 84
2017
Q2 		$521K Buy
9,350
+3,170
+51% +$172K 0.33% 77
2017
Q1 		$336K Buy
6,180
+1,000
+19% +$54.8K 0.28% 70
2016
Q4 		$303K Buy
5,180
+2,180
+73% +$119K 0.23% 77
2016
Q3 		$162K Hold
3,000
– – 0.14% 106
2016
Q2 		$221K Buy
3,000
+70
+2% +$4.95K 0.2% 84
2016
Q1 		$187K Buy
2,930
+100
+4% +$6.31K 0.17% 93
2015
Q4 		$195K Buy
+2,830
New +$187K 0.17% 94

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Grove Bank & Trust's BMY Position: Q2 2026 in Review

Grove Bank & Trust increased its Bristol-Myers Squibb (BMY) stake by 19% in Q2 2026, buying an estimated $203K and bringing the position to 22,434 shares worth $1.29M. The position accounts for 0.13% of the portfolio, ranked #99.

Grove Bank & Trust first reported a position in BMY in Q4 2015 and has held it in 43 quarters since. 888 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Grove Bank & Trust held 22,434 shares of Bristol-Myers Squibb worth $1.29M as of Q2 2026.
  • Grove Bank & Trust bought 3,532 Bristol-Myers Squibb shares in Q2 2026, an estimated $203K.
  • Bristol-Myers Squibb made up 0.13% of Grove Bank & Trust's portfolio in Q2 2026, its #99 holding.
  • Grove Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 43 quarters since.
  • 888 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.